Skip to main content
All lobbying filings

WILLOW LABORATORIES

Lobbying for WILLOW LABORATORIES · technology company

 Filing 3rd Quarter - Amendment
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 1, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
California

Official filing document

 Government bodies contacted 3
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 3
Health Issues

Support for funding, coverage and reimbursement for diabetes prevention and wellness technologies; patient safety; support for PBM reform.

Medicare/Medicaid

Support for increased Medicare and Medicaid coverage and reimbursement for diabetes prevention technologies; support for CMS TEAM Model [CMMI]

Financial Institutions/Investments/Securities

corporate governance and transparency

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem